| Name | Title | Contact Details |
|---|
At the Gibraltar International Bank, we believe that empowering you to manage your money easily is key. We have invested in state-of-the-art technology and online banking so that you can conduct your banking in whatever situation you may find yourself. There really is so much that we can offer both personal and corporate clients. To discover what we can do for you, just get in touch using the details below. We would love to hear from you. Phone +350 (200) 13900 Email gibraltar@gibintbank.gi
MITY Incorporated is a worldwide leader in helping customers optimize their facilities with innovative furniture solutions. Our product brands MityLite®, Holsag®, Bertolini®, and XpressPort®. The products manufactured by our brands deliver the safety, ease of use, and functional design needed for businesses in industries such as hospitality, worship, education, senior living, restaurant, and government. With worldwide headquarters in Orem, Utah operating since 1987, MITY now has offices and manufacturing facilities in Tennessee, Missouri, and Ontario. QUALITY ENGINEERING: Detailed design and superior manufacturing go into every product built by MITY product brands. We stand by our strong warranty program and commitment to excellent customer service. INNOVATIVE PRODUCTS: ABS Folding Tables, stacking banquet chairs, folding chairs, portable dance floors, mobile banquet tables, and linenless tables with integrated power—we offer the best! OUR SECRET SAUCE: We have the most elite, creative, and passionate team of employees in the industry! They are committed to serving our business partners. Interested in joining our team or doing business with MITY? Email info@mityinc.com or call 800-909-8034.
Were redefining the essence of classic ownership—vehicles not just restored, but entirely reborn. Our name ‘Velocity mirrors the swift pace at which were transforming the industry, setting a new benchmark for todays modern classic enthusiast.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.